IMRN — Immuron Ltd
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1660046 ·
Last close
$1.16
Market Cap
$9.36M
52W High
$2.39
52W Low
$0.68
ADV30
4,361,056
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2025 | — | — | — | — | 15,137,584 | 9,995,328 | 2,061,145 |
| Jun 2025 | — | — | — | — | 10,129,842 | 2,830,526 | 2,060,787 |
| Dec 2024 | — | — | — | — | — | 7,736,398 | 1,830,238 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-83,285,019
Inventory
$2,241,552
Receivables
$2,524,651
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$7,713,601
EBITDA
$-3,959,737
Free Cash Flow
$-2,319,899
Enterprise Value
$2,874,972
Total Cash
$9,017,814
Total Debt
$189,543
Shares Out
8,071,202
Trailing EPS
$-0.37
Book Value
$0.98
ROE
-40.2%
ROA
-21.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Jun 2025 | 7,287,002 | -5,356,731 | -5,215,987 | 10,129,842 | 2,060,787 | 8,069,055 | — |
| Jun 2024 | 4,902,865 | -5,215,839 | -6,936,957 | 15,549,969 | 2,840,525 | 12,709,444 | — |
| Jun 2023 | 1,804,705 | -3,406,520 | -3,786,507 | 21,988,182 | 2,371,346 | 19,616,836 | — |
| Jun 2022 | 765,193 | -3,117,413 | -2,854,254 | 24,855,824 | 1,678,423 | 23,177,401 | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.01
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| APRE | Aprea Therapeutics, Inc. | $9.47M | $0.75 | — |
| MDCX | Medicus Pharma Ltd. | $9.61M | $0.15 | — |
| APUS | Apimeds Pharmaceuticals US, Inc. | $9.64M | $6.39 | — |
| NRSN | NeuroSense Therapeutics Ltd. | $9.67M | $5.10 | — |
| FBLG | FibroBiologics, Inc. | $9.06M | $1.36 | — |
News headlines (Yahoo Finance, 1h cache)
IMRN Stock Skyrockets 60%, Heads For Best Day In Over 2 Years – What’s Driving The Super Rally Today?
2026-09-04 14:50 · Yahoo
Immuron Plans U.S. PROIBS Launch Under Exclusive Distribution Agreement
2026-09-04 13:53 · Yahoo
Immuron to launch PROIBS® in the United States
2026-09-04 10:00 · Yahoo
Sector Update: Healthcare Stocks Decline Late Afternoon
2026-09-04 19:48 · Yahoo
Sector Update: Healthcare Stocks Decline Friday Afternoon
2026-09-04 17:41 · Yahoo
Immuron Reports FY26 Preliminary Results
2026-08-28 10:00 · Yahoo
Presenting on Emerging Growth Conference 95 Day 1 on August 19; Register to live stream
2026-08-18 11:00 · Yahoo
Immuron FY26 Sales - Four Consecutive Quarters of Growth over Prior Year
2026-07-16 10:00 · Yahoo
Immuron Advances IMM-529 (Clostridioides difficile infection) Partnering Strategy
2026-07-06 10:00 · Yahoo
Presenting on Emerging Growth Conference 92 Day 2 on May 7; Register to live stream
2026-05-06 11:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.